ArticleBlood2022

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.

Hua-Jay J Cherng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.